Cargando…
Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase
The oncogenic fusion protein RUNX1-ETO is a product of the t(8;21) translocation and consists of the hematopoietic transcriptional master regulator RUNX1 and the repressor ETO. RUNX1-ETO is found in 10–15% of acute myeloid leukemia and interferes with the expression of genes that are essential for m...
Autores principales: | Schoenherr, Caroline, Wohlan, Katharina, Dallmann, Iris, Pich, Andreas, Hegermann, Jan, Ganser, Arnold, Hilfiker-Kleiner, Denise, Heidenreich, Olaf, Scherr, Michaela, Eder, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905530/ https://www.ncbi.nlm.nih.gov/pubmed/31826021 http://dx.doi.org/10.1371/journal.pone.0225977 |
Ejemplares similares
-
miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo
por: Lee, Chun-Wei, et al.
Publicado: (2018) -
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
por: Scherr, Michaela, et al.
Publicado: (2018) -
Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart
por: Kirchhoff, Hanna, et al.
Publicado: (2022) -
The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype
por: Forster, V J, et al.
Publicado: (2016) -
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
por: Ptasinska, A, et al.
Publicado: (2012)